- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT06665672
Ranteessa pidettävän laitteen, joka tuottaa pientä tärinää, vaikutus uneen ja suorituskykyyn, joka voi esiintyä yövuorotyön aikana ja sen jälkeen (Sleep-Vibe)
Vibroakustisen stimulaation vaikutus yövuorotyöntekijän uneen, valppauteen ja palautumiseen (The Sleep Vibe Study)
The overarching goal of this research study is to determine "proof of concept" of effect of a non-invasive sleep aid device on sleep and performance during sleep opportunities (naps) that occur during and after simulated night shift work.
Aim 1: To determine the effect of the ApolloNeuro device on sleep duration, sleep architecture, blood pressure, heart rate variability, and subjective ratings of sleep quality during and after simulated night shift work.
Aim 2: To determine the effect of the ApolloNeuro device on post-sleep psychomotor performance.
Tutkimuksen yleiskatsaus
Tila
Interventio / Hoito
Yksityiskohtainen kuvaus
Night shift workers suffer from poor sleep quality, high levels of fatigue, and irregular sleep patterns. The overarching goal of this research study is to determine "proof of concept" of effect of a non-invasive sleep aid device on sleep and performance during sleep opportunities (naps) that occur during and after simulated night shift work. The device is commercially available and worn on the wrist (the ApolloNeuro). We will use a laboratory-based, randomized crossover trial with two conditions tested. With 24 total subjects enrolled and 20 total completing the study as designed, we have 80% power to detect a moderate to large effect size difference between the two conditions tested. Study findings will guide a "go-no-go" decision for future, large-sample studies.
The original description of the BP dipping outcome was not clear and combined two different approaches to presenting BP dipping measures: a count/proportion type measure of those with or without a dip, and a continuous measure - the percentage dip (0-100%). When reporting our results, we edited the description in the results section to improve clarity of our measure description.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Yhdysvallat, 15261
- University of Pittsburgh
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- are 18 years of age or older;
- have not been diagnosed or told by a healthcare clinician that they have a medical condition that may impact their blood pressure or cardiovascular health/system;
- can abstain from smoking tobacco or chewing tobacco / nicotine products during the protocol and data collection;
- can abstain from alcohol and moderate to high intensity exercise during the protocol and data collection;
- are not prescribed medications or take over the counter medications that may impact blood pressure or heart rate (a team physician will review any reported medications identified during screening);
- do not have a physical condition that may interfere with application of non-invasive devices on the wrist, upper arm, or chest for purposes of data collection with non-invasive devices;
- feel that they can avoid working and complete the study protocol without interruption.
- a public safety or healthcare shift worker based on standard licensing / certification requirements in the state of Pennsylvania.
Exclusion Criteria:
An individual will be excluded if they report:
- a medical condition or diagnosis that may impact their blood pressure or heart rate;
- taking any standing medications or prescriptions, other than over the counter medications or contraceptives, that may impact their blood pressure or heart rate;
- are unable to adhere to the study protocol that involves abstaining from alcohol, tobacco products (nicotine), and moderate to intense exercise during the study protocol and data collection periods;
- have a physical condition that may limit use of non-invasive devices applied to the wrist, upper arm, or chest for data collection purposes.
- being pregnant.
- "heavy" alcohol use as defined by the CDC (8 or more drinks per week in women or 15 or more drinks per week in men)?
Because participants will have their sleep interrupted during the in-lab sleep opportunity, it is important that staff and the study team know if the participant has ever experienced the following:
A] Sleep Paralysis; B] Night Terrors; C] Have Obstructive Sleep Apnea which requires the use of a CPAP Device; D] Become angry towards others when abruptly woken up; E] Become physical towards others when abruptly woken up.
Mild annoyance and feelings of fatigue or sleepiness with being woken by staff is expected and not a reason for exclusion in this research study.
Answering YES to any of the above (A-E) will result in a discussion with the study team physician to discuss with the individual and make a determination if the individual can or should participate in this research study.
All who voluntarily participate should be without significant health issues and without health concerns that may affect their blood pressure.
All who voluntarily participate should not be on medications that fall within the following categories:
A] Antihypertensives; B] Analgesics; C] Beta blockers; D] Diuretics; E] Stimulants; F] Sedatives; G] Steroids.
Participants must not take any medications with sedative effects or effects on sleep during the study protocol and data collection periods (such as NyQuil).
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Perustiede
- Jako: Satunnaistettu
- Inventiomalli: Crossover-tehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Apollo device applied followed by no device applied
Participants will be randomized to first wear the Apollo Neuro device immediately before, during, and immediately after sleep opportunities during the study protocol. Next, the participant will complete the protocol without the device. |
The Apollo device is a wrist worn device that is similar to a typical wristwatch. It emits a vibration pattern based on settings selected on a designated mobile app.
Muut nimet:
|
|
Kokeellinen: No device applied followed by the Apollo device applied
Participants will be randomized to first complete the protocol without the Apollo Neuro device applied then complete a condition with the Apollo Neuro device applied immediately before, during, and immediately after sleep opportunities during the study protocol. |
The Apollo device is a wrist worn device that is similar to a typical wristwatch. It emits a vibration pattern based on settings selected on a designated mobile app.
Muut nimet:
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Mean Sleep Duration
Aikaikkuna: Two time points examined. First, from the start of the simulated night shift 30-minute nap opportunity to the end at 30 minutes. Second, from the start of the recovery sleep period starting at 9am and ending at 2pm.
|
Sleep duration is measured in minutes |
Two time points examined. First, from the start of the simulated night shift 30-minute nap opportunity to the end at 30 minutes. Second, from the start of the recovery sleep period starting at 9am and ending at 2pm.
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Mean Number of Lapses in Psychomotor Performance at 10 Minutes After Participants Wake From Sleep Period
Aikaikkuna: Measured at two time points. First, measured at 10 minutes after waking from the 30-minute nap opportunity during the simulated night shift. Second, measured at 10 minutes after participants wake from the 5-hour recovery sleep period..
|
The 3-minute Psychomotor Vigilance Test Brief (PVT-B) is a reliable and valid measure of psychomotor performance. Investigators administered the PVT-B with an iPad device at 10 minutes after waking from the 30-minute simulated shift nap opportunity. Lapses of attention defined as response times ≥ 355 milliseconds on the PVT-B, as established by Basner et al. (2011). Reference: Basner, M., Mollicone, D., & Dinges, D. F. (2011). Validity and sensitivity of a brief psychomotor vigilance test (PVT-B) to total and partial sleep deprivation. Acta Astronautica, 69(11-12), 949-959. |
Measured at two time points. First, measured at 10 minutes after waking from the 30-minute nap opportunity during the simulated night shift. Second, measured at 10 minutes after participants wake from the 5-hour recovery sleep period..
|
|
A Dip in Systolic Blood Pressure or Diastolic Blood Pressure During 30-min Nap Opportunity and During the 5-hour Recovery Sleep Period That is Greater Than or Equal to 10%
Aikaikkuna: During the 30-min nap opportunity and 5-hour recovery sleep period that occurs during the simulated 24-hour night shift
|
A dip > = 10% in systolic blood pressure (SBP) and/or diastolic blood pressure (DBP) during the 30-min nap opportunity and during the 5-hour recovery sleep period. Dipping defined as ((mean wake hours SBP - mean sleep SBP divided by mean wake hours SBP) X 100). |
During the 30-min nap opportunity and 5-hour recovery sleep period that occurs during the simulated 24-hour night shift
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Päätutkija: Paul D Patterson, PhD, University of Pittsburgh
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muut tutkimustunnusnumerot
- STUDY24060106
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
De-identified study data may be provided to researchers at the University of Pittsburgh, other institutions and/or federal repositories for the purposes of collaboration on the proposed research. Sharing will be completed under an approved sharing agreement.
IPD-jaon aikakehys
December 2026
IPD-jaon käyttöoikeuskriteerit
Reviewed on a case by case basis
IPD-jakamista tukeva tietotyyppi
- STUDY_PROTOCOL
- ICF
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Yhdysvalloissa valmistettu ja sieltä viety tuote
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .